Skip to main content
Premium Trial:

Request an Annual Quote

Court to Reconsider Part of Ruling in Illumina, Complete Genomics IP Suit

NEW YORK (GenomeWeb News) – The US District Court for the Northern District of California has agreed to reconsider part of its recent ruling in a patent dispute between Illumina and Complete Genomics, Illumina said today.

Last month the District Court had granted partial summary judgment in favor of Complete Genomics. Specifically, the court ruled that certain claims in Illumina's US Patent No. 6,306,597, which covers DNA sequencing by parallel oligonucleotide extensions, the use of arrayed biomolecules in sequencing, and methods and compositions for ordering restriction fragments, were invalid.

Illumina said today that the court has agreed to allow the firm to file a brief asking the court to reconsider its earlier ruling invalidating claims 14 and 15 of the '597 patent. Illumina said that it would seek a Jan. 8, 2013 hearing date on the motion for reconsideration.

"We continue to believe that this patent covers important and novel inventions that Complete Genomics has misappropriated," Illumina President and CEO Jay Flatley said in a statement.

The litigation is taking place amid Illumina's recent bid to acquire Complete Genomics, which already has inked a deal to merge with BGI-Shenzhen. Illumina has offered a 5 percent premium to the $3.15 per-share price that BGI has agreed to pay, and last week Flatley sent a letter to Complete Genomics' board urging them to reconsider the competing bid.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.